Bristol Myers Squibb Co. (BMY)
67.31
+0.30
(+0.45%)
USD |
NYSE |
Aug 24, 16:00
67.13
-0.18
(-0.27%)
After-Hours: 20:00
Bristol Myers Squibb 1 Year Total Returns (Daily) : 44.96% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 44.96% |
| August 20, 2026 | 42.13% |
| August 19, 2026 | 46.53% |
| August 18, 2026 | 43.59% |
| August 17, 2026 | 39.78% |
| August 14, 2026 | 39.87% |
| August 13, 2026 | 41.55% |
| August 12, 2026 | 43.36% |
| August 11, 2026 | 45.09% |
| August 10, 2026 | 47.84% |
| August 07, 2026 | 49.48% |
| August 06, 2026 | 49.95% |
| August 05, 2026 | 45.39% |
| August 04, 2026 | 52.05% |
| August 03, 2026 | 55.08% |
| July 31, 2026 | 57.98% |
| July 30, 2026 | 47.78% |
| July 29, 2026 | 41.07% |
| July 28, 2026 | 40.25% |
| July 27, 2026 | 35.33% |
| July 24, 2026 | 32.92% |
| July 23, 2026 | 31.57% |
| July 22, 2026 | 32.56% |
| July 21, 2026 | 36.72% |
| July 20, 2026 | 33.08% |
| Date | Value |
|---|---|
| July 17, 2026 | 32.41% |
| July 16, 2026 | 34.39% |
| July 15, 2026 | 32.50% |
| July 14, 2026 | 26.03% |
| July 13, 2026 | 32.67% |
| July 10, 2026 | 24.33% |
| July 09, 2026 | 27.36% |
| July 08, 2026 | 28.15% |
| July 07, 2026 | 30.64% |
| July 06, 2026 | 26.60% |
| July 02, 2026 | 29.55% |
| July 01, 2026 | 24.75% |
| June 30, 2026 | 30.72% |
| June 29, 2026 | 32.68% |
| June 26, 2026 | 29.48% |
| June 25, 2026 | 24.61% |
| June 24, 2026 | 22.81% |
| June 23, 2026 | 24.28% |
| June 22, 2026 | 22.58% |
| June 18, 2026 | 21.06% |
| June 17, 2026 | 22.91% |
| June 16, 2026 | 20.68% |
| June 15, 2026 | 18.71% |
| June 12, 2026 | 18.35% |
| June 11, 2026 | 19.12% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Johnson & Johnson | 54.80% |
| Eli Lilly & Co. | 77.98% |
| Merck & Co., Inc. | 83.18% |
| Pfizer Inc. | 16.73% |
| AstraZeneca PLC | 4.92% |